These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23657524)

  • 1. Screening of reducing agents for the PEGylation of recombinant human IL-10.
    Ambrogelly A; Cutler C; Paporello B
    Protein J; 2013 Jun; 32(5):337-42. PubMed ID: 23657524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyridine Borane as Alternative Reducing Agent to Sodium Cyanoborohydride for the PEGylation of L-asparaginase.
    Gurram S; Srivastava G; Badve V; Nandre V; Gundu S; Doshi P
    Appl Biochem Biotechnol; 2022 Feb; 194(2):827-847. PubMed ID: 34550501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-picoline-borane: a non-toxic reducing agent for oligosaccharide labeling by reductive amination.
    Ruhaak LR; Steenvoorden E; Koeleman CA; Deelder AM; Wuhrer M
    Proteomics; 2010 Jun; 10(12):2330-6. PubMed ID: 20391534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of plant cell wall monosaccharides by reversed-phase liquid chromatography with 2-aminobenzamide pre-column derivatization and a non-toxic reducing reagent 2-picoline borane.
    Fang J; Qin G; Ma J; She YM
    J Chromatogr A; 2015 Oct; 1414():122-8. PubMed ID: 26342873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carboxyalkylated histidine is a pH-dependent product of pegylation with SC-PEG.
    Wylie DC; Voloch M; Lee S; Liu YH; Cannon-Carlson S; Cutler C; Pramanik B
    Pharm Res; 2001 Sep; 18(9):1354-60. PubMed ID: 11683252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Bioconjugation Strategy Using Elevated Hydrostatic Pressure: A Case Study for the Site-Specific Attachment of Polyethylene Glycol (PEGylation) of Recombinant Human Ciliary Neurotrophic Factor.
    Wang Q; Zhang C; Guo F; Li Z; Liu Y; Su Z
    Bioconjug Chem; 2017 Nov; 28(11):2841-2848. PubMed ID: 29053917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of PEGylation and immune complex formation on the pharmacokinetics and biodistribution of recombinant interleukin 10 in mice.
    Alvarez HM; So OY; Hsieh S; Shinsky-Bjorde N; Ma H; Song Y; Pang Y; Marian M; Escandón E
    Drug Metab Dispos; 2012 Feb; 40(2):360-73. PubMed ID: 22083830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative reducing agents for reductive methylation of amino groups in proteins.
    Geoghegan KF; Cabacungan JC; Dixon HB; Feeney RE
    Int J Pept Protein Res; 1981 Mar; 17(3):345-52. PubMed ID: 7287304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PEGylation prevents the N-terminal degradation of megakaryocyte growth and development factor.
    Guerra PI; Acklin C; Kosky AA; Davis JM; Treuheit MJ; Brems DN
    Pharm Res; 1998 Dec; 15(12):1822-7. PubMed ID: 9892464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Labeling of oligosaccharides for quantitative mass spectrometry.
    Unterieser I; Mischnick P
    Carbohydr Res; 2011 Jan; 346(1):68-75. PubMed ID: 21118748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PEGylation of interleukin-10 for the mitigation of enhanced pain states.
    Soderquist RG; Milligan ED; Harrison JA; Chavez RA; Johnson KW; Watkins LR; Mahoney MJ
    J Biomed Mater Res A; 2010 Jun; 93(3):1169-79. PubMed ID: 19768789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Locational Impact of Site-Specific PEGylation: Streamlined Screening with Cell-Free Protein Expression and Coarse-Grain Simulation.
    Wilding KM; Smith AK; Wilkerson JW; Bush DB; Knotts TA; Bundy BC
    ACS Synth Biol; 2018 Feb; 7(2):510-521. PubMed ID: 29295615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cysteine as a Monothiol Reducing Agent to Prevent Copper-Mediated Oxidation of Interferon Beta During PEGylation by CuAAC.
    Nairn NW; Bariola PA; Graddis TJ; VanBrunt MP; Wang A; Li G; Grabstein K
    Bioconjug Chem; 2015 Oct; 26(10):2070-5. PubMed ID: 26439457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emissive behavior, cytotoxic activity, cellular uptake, and PEGylation properties of new luminescent rhenium(I) polypyridine poly(ethylene glycol) complexes.
    Choi AW; Louie MW; Li SP; Liu HW; Chan BT; Lam TC; Lin AC; Cheng SH; Lo KK
    Inorg Chem; 2012 Dec; 51(24):13289-302. PubMed ID: 23198846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative antibody Fab' fragment PEGylation strategies: combination of strong reducing agents, disruption of the interchain disulphide bond and disulphide engineering.
    Humphreys DP; Heywood SP; Henry A; Ait-Lhadj L; Antoniw P; Palframan R; Greenslade KJ; Carrington B; Reeks DG; Bowering LC; West S; Brand HA
    Protein Eng Des Sel; 2007 May; 20(5):227-34. PubMed ID: 17452434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression, Purification, and Polyethylene Glycol Site-Specific Modification of Recombinant Human Interleukin 24 in Escherichia coli.
    Zhang Y; Ma Q; Wang J; Ge J; Hua J; Shi Y; Zhang C; Liu M; Wang Y; Chen Z; Wang Z; Liu Y; Jiang H
    Protein J; 2019 Oct; 38(5):576-585. PubMed ID: 31062210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel solid-phase site-specific PEGylation enhances the in vitro and in vivo biostabilty of recombinant human keratinocyte growth factor 1.
    Huang Z; Zhu G; Sun C; Zhang J; Zhang Y; Zhang Y; Ye C; Wang X; Ilghari D; Li X
    PLoS One; 2012; 7(5):e36423. PubMed ID: 22574160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure, biology, and therapeutic implications of pegylated interferon alpha-2b.
    Youngster S; Wang YS; Grace M; Bausch J; Bordens R; Wyss DF
    Curr Pharm Des; 2002; 8(24):2139-57. PubMed ID: 12369859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation on PEGylation strategy of recombinant human interleukin-1 receptor antagonist.
    Yu P; Zheng C; Chen J; Zhang G; Liu Y; Suo X; Zhang G; Su Z
    Bioorg Med Chem; 2007 Aug; 15(16):5396-405. PubMed ID: 17561403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving Properties of Recombinant SsoPox by Site-Specific Pegylation.
    Parikh H; Bajaj P; Tripathy RK; Pande AH
    Protein Pept Lett; 2015; 22(12):1098-103. PubMed ID: 26428299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.